Physician profile
Norman Mcnulty
NPI 1013195452
$1,634.56
in general payments reported to CMS, 2019-2025
16 companies · $83.71 in 2025
The $83.71 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $54.28 · 2021: $196 · 2022: $164 · 2023: $368 · 2024: $166 · 2025: $83.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521 · Education: $96.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.15 |
| Education | $96.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $255.66 | 2019-2023 | |
| Sk Life Science, INC. | $253.93 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $231.57 | 2023-2024 | Aptiom |
| Abbvie INC. | $193.25 | 2021-2022 | |
| Genzyme Corporation | $170.34 | 2019-2022 | |
| Lilly USA, LLC | $160.25 | 2019-2023 | Reyvow, Emgality |
| Amgen INC. | $76.62 | 2019-2020 | |
| Ucb, INC. | $53.63 | 2019 | |
| Sunovion Pharmaceuticals INC. | $45.66 | 2022 | |
| Emd Serono, INC. | $44.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.46 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $34.77 | 2024-2025 | Ultomiris |
| Allergan, INC. | $20.93 | 2020 | |
| Avanir Pharmaceuticals, INC. | $19.46 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.00 | 2023 | Nuedexta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Mcnulty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.